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Abstract.
Introduction: Detecting functional decline from normal ageing to dementia is
relevant for diagnostic and prognostic purposes. Therefore, the Amsterdam
IADL Questionnaire (A-IADL-Q) was developed: A 70-item proxy-based tool
with good psychometric properties. We aimed to design a short version whilst
preserving its psychometric quality.
Methods: Study partners of subjects (n = 1355), ranging from cognitively
normal to dementia subjects, completed the original A-IADL-Q. We selected
the short version items using a stepwise procedure combining missing data,
Item Response Theory and input from respondents and experts. We investi-
gated internal consistency of the short version as well as concordance with the
original version. To assess its construct validity, we additionally investigated
concordance between the short version and the Mini-Mental State Exami-
nation (MMSE) and Disability Assessment for Dementia (DAD). Lastly, we
investigated differences in IADL scores between diagnostic groups across the
dementia spectrum.
Results: We selected 30 items covering the entire spectrum of IADL function-
ing. Internal consistency (.98) and concordance with the original version (.97)
were very high. Concordance with the MMSE (.72) and DAD (.87) scores was
high. IADL impairment scores increased across the spectrum from normal
cognition to dementia.
Discussion: The A-IADL-Q Short Version (A-IADL-Q-SV) consists of 30
items. The A-IADL-Q-SV has maintained the psychometric quality of the
original A-IADL-Q. As such, it is a concise measure of functional decline.
Key words: Alzheimer’s disease; Dementia; Instrumental activities of daily
living; Item response theory; Functional decline; Mild cognitive impairment;
Subjective cognitive decline
Abbreviations: AD = Alzheimer’s disease; A-IADL-Q = Amsterdam IADL
Questionnaire; CFI = Comparative fit index; DAD = Disability Assessment
for Dementia; IADL = Instrumental activities of daily living; IIC = Item
information curve; IRT = Item response theory; GRM = Graded response
model; LRT = Likelihood ratio test; MCI = Mild cognitive impairment; MML
= Marginal maximum likelihood; MMSE = Mini-Mental State Examination;
NC = Normal cognition; RMSEA = Root mean square error of approximation;
SCD = Subjective cognitive decline; SD = Standard deviation; VAS = Visual
analogue scale; VUmc = VU University Medical Center
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1. Background
Dementia is a syndrome characterized by progressive cognitive decline and sig-
nificant interference in daily function [1]. The first observable problems in daily
life often concern the Instrumental Activities of Daily Living (IADL). IADL can be
defined as ‘complex activities for which multiple cognitive processes are necessary’,
such as cooking, managing finances and driving [2]. Detecting functional decline
along the continuum from normal ageing to dementia is highly relevant for a number
of reasons. First of all, subtle IADL problems may already be present in subjects
with Mild Cognitive Impairment (MCI) and predict progression to dementia [3-5].
This suggests that assessment of IADL can be used to select MCI subjects at an
increased risk for dementia [6]. Once a diagnosis has been established, measuring
IADL performance remains essential for the monitoring of clinical progression [7].
Lastly, IADL assessment plays a pivotal role in clinical trials, particularly in the
evaluation of symptomatic treatment in dementia due to Alzheimer’s disease (AD)
[8-10].
IADL performance is often measured using proxy-based questionnaires [11]. Un-
fortunately, most of these questionnaires suffer from serious limitations. They focus
on everyday activities that are outdated and less relevant for patients in the early
stages of dementia [12]. Furthermore, psychometric properties such as reliability,
validity and responsiveness are often questionable or overlooked [13]. Recent studies
have pointed out that improvements in IADL instruments are necessary, especially
for detecting IADL problems in MCI and the early stages of dementia [14-17].
To overcome the above mentioned drawbacks of existing IADL scales, Sikkes et
al. developed the Amsterdam IADL Questionnaire (A-IADL-Q). The A-IADL-Q is
a 70-item proxy-based tool and was developed with input from clinicians, patients
and caregivers [18]. Previous studies have reported good psychometric properties
with respect to reliability, validity, responsiveness and diagnostic accuracy in de-
mentia [19-21]. One disadvantage of the A-IADL-Q is its length, resulting in an
administration time of 20-25 minutes. Additionally, respondents often report that
some items are redundant or unclear. To facilitate its administration and imple-
mentation on a wider scale, we aimed to design a short and more concise version
of the A-IADL-Q.
The present paper describes the development and validation of a short version of
the A-IADL-Q. We aimed to select the most informative items, using a combined
approach of quantitative and qualitative methods. We expected that the short
version would maintain the good psychometric quality of the original A-IADL-Q.
Additionally, we expected that IADL scores based on the short version would differ
between diagnostic groups across the spectrum from normal cognition to dementia.
2. Methods
2.1. Subjects. We selected 1355 subjects with different levels of cognitive func-
tioning, ranging from normal cognition to dementia. Their study partner, mainly a
spouse, relative or friend, completed the A-IADL-Q. We included subjects from neu-
rological memory clinics of the VU University Medical Center (VUmc) Alzheimer
Center, Amsterdam, The Netherlands (n = 1117), and the Alzheimer Center Rot-
terdam, The Netherlands (n = 32) and from the geriatric memory clinic of the
VUmc, Amsterdam, The Netherlands (n = 102). All these subjects underwent a
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dementia assessment, including clinical history, medical and neurological examina-
tion, screening laboratory tests, a neuropsychological test battery and brain imaging
[22]. During this visit, study partners completed the A-IADL-Q on an iPad. Sub-
jects’ diagnoses were made in a multidisciplinary diagnostic meeting, containing at
least a neurologist or geriatrician[3,22,23].
We included cognitively normal subjects (n = 104) from the Amsterdam site
of the preclinAD cohort of the European Medical Information Framework for
Alzheimer’s disease (EMIF-AD) project. Inclusion criteria for this cohort were:
age ≥ 60, Modified Telephone Interview for Cognitive Screening > 22; Geriatric
Depression Scale < 11; Consortium to Establish a Registry for Alzheimer’s Disease
10 word list delayed recall > 1.5 SD of age adjusted normative data; and Clinical
Dementia Rating score of 0 with a score on the memory sub-domain of 0 [24-27].
During the baseline visit, study partners completed the A-IADL-Q on an iPad.
Data were collected between October 2012 and August 2015. All subjects gave
written informed consent and all study partners gave oral informed consent. The
Medical Ethical Committee of the VU University Medical Center approved the
study.
2.2. The Amsterdam IADL Questionnaire. The original A-IADL-Q is a proxy-
based scale with 70 items covering a broad range of cognitive IADL [18]. The items
can be divided into eight subcategories: household, administration, work, com-
puter use, leisure time, appliances, transport and other activities. The A-IADL-Q
is computerized and has an adaptive approach as the items are tailored to indi-
vidual responses (see Figure 1). This results in a minimum of 47 and a maximum
of 70 items for each respondent. Prior to the start, it is emphasized that the
questionnaire addresses day-to-day problems caused by cognitive problems, such
as memory, attention, or planning problems. Difficulty in performance is rated on
a 5-point Likert scale, ranging from ‘no difficulty in performing this task’ to ‘no
longer able to perform this task’. Scoring is based on Item Response Theory (IRT):
a paradigm linking responses to a test battery to an underlying construct (or latent
trait) [28]. For the A-IADL-Q, the construct underlying the items can be termed
‘IADL performance’. That is, the latent trait reflects IADL impairment with higher
estimated trait levels indicating more impairment.
Linking the probabilities of category-specific item responses to latent trait levels
is based on an IRT model [28]. For the A-IADL-Q, the Graded Response Model
(GRM) is used: a polytomous IRT model appropriate for items with ordinal re-
sponse categories [29]. In the GRM, each item is characterized by a discrimi-
nation parameter (α) and 4 extremity parameters (β’s; the number of response
categories minus 1). The discrimination (or slope) parameter indicates how well
an item discriminates between individuals with differing trait levels: higher dis-
crimination parameters suggest higher ability to differentiate. The extremity (or
category threshold) parameters represent the trait levels that mark the transition
between response categories (in terms of cumulative probabilities for endorsement)
[29]. An important advantage of IRT is that one’s level of the latent trait can be es-
timated from any set of items for which the parameters are known. Therefore, IRT
is able to handle missing data that may result from an adaptive approach. IRT is
often preferred over classical scoring methods for scale development and refinement:
it advances the development of more efficient scales by supporting item-reduction
whilst preserving measurement precision [30,31].
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o Yes 
 
Did he/she find it more difficult to perform household duties than he/she had in the 
past? 
 
o No (0) 
o Yes, slightly more difficult (1) 
o Yes, more difficult (2) 
o Yes, much more difficult (3) 
o Yes, he/she is no longer able to perform this task (4) 
 
 
  
o No  
 
He/she did not carry out any household duties for the following reason:  
 
o He/she was unable to do so due to his/her cognitive problems (4) 
o He/she was unable to do so due to his/her physical problems (-) 
o He/she has never done that before (-) 
o Other, please state ……………… (-) 
Did he/she carry out household duties in the past 4 weeks? 
o Don’t know  
 
Item scored as missing (-). Questionnaire skips to next item.  
Figure 1. Example item of the A-IADL-Q, including response
options and scoring.
The following basic assumptions underlie the IRT framework: (1) Unidimension-
ality, implying that a single latent trait underlies the items; (2) Local independence,
which implies independence of item responses conditional on the latent trait; and
(3) Monotonicity, implying that the probability of endorsing (a category-specific
response to) an item should increase as the trait level increases [32]. Previous work
showed that the A-IADL-Q could be adequately described by a single latent factor
and that the assumptions of local independence and monotonicity were met as well
[19]. Since the current study contains a larger and more heterogenic sample, we
have assessed these basic assumptions again.
2.3. Procedures. We divided the total sample into a training (n = 677) and val-
idation set (n = 678), to use independent samples for the development and valida-
tion of the short version. We randomly split the Alzheimer Center Rotterdam, the
VUmc geriatric and the cognitively healthy cohorts. We conducted an alternative
split procedure for the VUmc Alzheimer Center cohort (n = 1117), as a subsample
(n = 206) of this cohort was used for the validation of the original A-IADL-Q.
We therefore assigned this entire subsample to the current training set. From the
remaining subjects (n = 911) we randomly assigned 35% to our training set and
65% to our validation set, to ensure that both sets had equal group sizes.
2.3.1. Development procedure. Item selection was performed in the training set,
using a stepwise procedure that combined missing data, IRT and content aspects.
As shown in Figure 1, a response is scored as missing when (1) the particular task
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has not been performed due to other reasons rather than cognitive problems or (2)
the study partner does not know whether the subject has performed that particular
task in the past four weeks. Items with higher percentages of missing responses give
us a less direct view of cognitive IADL, and are thus less applicable for our goal.
We therefore eliminated items with more than 80% overall missing data. Items
with more than 60% missing data in all diagnostic groups were candidates for
elimination.
IRT analyses. We explored whether all items met the basic assumptions for
IRT and eliminated items that did not meet these conditions. In the subsequent
refitting rounds, we used IRT to identify items that contributed little unique infor-
mation to the model, as reflected in either low item information values (an index
representing the precision with which the trait is measured) or overlapping Item
Information Curves (IIC’s; a mapping of the item information to the domain of the
trait indicating how the information is distributed over the trait) with other items.
After each elimination round, the GRM was refitted and an overall fit-assessment
was performed. This resulted in new item parameters and IIC’s that were used in
the succeeding refitting round.
Content aspects. Comprehensibility was investigated in two ways: (1) by inspect-
ing the comments that respondents provided in the ‘comment box’ after completing
the A-IADL-Q; and (2) performing thinking-out-loud interviews in a subsample of
respondents (n = 17) whilst they were completing the A-IADL-Q. Items that were
often commented as unclear or redundant, in either the comment box or inter-
view, were candidates for removal. Furthermore, we investigated relevance and
cultural applicability of all A-IADL-Q items with an online survey that we dis-
tributed among international experts. Between February 2016 and May 2016, we
distributed the survey through contacts of the authors (R.J.J. and S.A.M.S.) via
Qualtrics (www.qualtrics.com). All respondents (n = 33) were clinicians or re-
searchers representing 7 countries, and had experience with the administration or
cross-cultural validation of the A-IADL-Q. They were asked to rate the necessity of
each original A-IADL-Q item for inclusion in the short version on a visual analogue
scale (VAS) ranging from 0 (‘not necessary at all’) to 100 (‘very necessary’).
2.3.2. Validation procedure. To confirm the quality of the final short version, we in-
vestigated missing data patterns, experts’ ratings, adherence to IRT assumptions,
as well as the overall fit of the short version items in the validation set. We sub-
sequently investigated internal consistency of the short version and concordance
between sum scores derived from the short and original version. To assess con-
struct validity [33], we investigated the relationship between the short version and
measures of global cognition (Mini-Mental State Examination; MMSE [34]) and
daily function (Disability Assessment for Dementia; DAD [35]), which were avail-
able for the VUmc Alzheimer Center cohort. Based on previous results [19], we
expected moderate-to-high concordance between the short version and MMSE and
DAD scores. To assess interpretability of the short version, we investigated differ-
ences in scores between six diagnostic groups that should represent different trait
levels: (1) normal cognition (NC); (2) subjective cognitive decline (SCD); (3) mild
cognitive impairment (MCI); (4) dementia due to AD (AD dementia); (5) demen-
tia other than AD (non-AD dementia); and (6) another neurological or psychiatric
disorder than dementia (Other).
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2.4. Statistical analyses. Statistical analyses were performed using R and SPSS
version 20.0 [36,37]. Statistical significance (for multiplicity corrections) was set at
p < .05.
2.4.1. Development analyses. Item selection was partly based on IRT modeling.
We used a GRM with a logit link function [29]. This model was fitted on the
basis of approximate marginal maximum likelihood (MML) estimation [38]. The
latent trait was assumed to follow a standard normal distribution. We assessed
unidimensionality by performing an eigenvalue decomposition on the matrix of ro-
bust (Spearman) correlations between the items. A difference approximation to
the second-order derivatives along the eigenvalue curve (scree plot) was calculated.
This acceleration-approximation indicates points of abrupt change along the eigen-
value curve [39]. The number of eigenvalues before the point with the most abrupt
change (the point with the maximum acceleration value) represents the number
of latent dimensions that dominate the information content. Local independence
was assessed by inspecting residual correlation matrices. We considered residual
correlations above .25 as indicative of problematic item pairs. We evaluated the
monotonicity assumption using Mokken scale analysis [40]. Items that gave at
least 1 significant violation of manifest monotonicity and had a crit value over 30
were considered to violate latent monotonicity [41]. We assessed basic model fit by
comparing nested models: we employed a likelihood ratio test (LRT) to evaluate
if the full GRM provided a better fit than a constrained GRM with equal slope
parameters across items [28].
2.4.2. Validation analyses. We fitted a GRM on the final set of retained items.
Estimation and assumption evaluation for this model were performed as described
above. This model was also compared to a constrained GRM as a means of basic
model fit assessment. In addition, we evaluated global fitness of the final model
with the comparative fit index (CFI) and root mean square error of approximation
(RMSEA) [42]. Trait (or factor) scores were then based on empirical Bayes esti-
mates: the mode of the posterior distribution of the trait given the retained items
evaluated at the MML estimates. We calculated internal consistency of the retained
items using a robust version of McDonald’s omega [43]. We examined concordance
between sum-scores derived from the short and original versions, as well as between
short version sum-scores and MMSE and DAD scores, using Kendall’s W [44]. To
assess whether the short version scores differed between the diagnostic groups, we
used a Kruskal-Wallis rank sum test on the trait scores followed by Dunn’s pairwise
test for multiple comparisons of mean rank sums (a nonparametric alternative to
ANOVA followed by post-hoc tests) [45]. Multiple testing correction was based on
the Bonferroni method.
3. Results
3.1. Sample and item characteristics. The study sample consisted of subjects
with NC (n = 104), SCD (n = 219), MCI (n = 138), AD dementia (n = 413),
non-AD dementia (n = 235) and 246 subjects with other diagnoses. Table 1 shows
subject characteristics for the total sample and for the training and validation set
separately. There were no age and gender differences between the two sets. The
MCI group was slightly larger in the training set, whilst the non-AD dementia
group was slightly larger in the validation set.
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Table 1. Subject characteristics. Abbreviations: NC = normal
cognition, SCD = subjective cognitive decline, MCI = mild cogni-
tive impairment, AD = Alzheimer’s disease. † Tested using inde-
pendent t-test. ‡ Tested using Pearson’s Chi-Square test.
Total sample Training set Validation set p-value
(n = 1355) (n = 677) (n = 678)
Age, M (SD) 65.7 (9.7) 66.1 (10.1) 65.3 (9.2) 0.146†
Gender, female (%) 602 (44.4%) 301 (44.5%) 301 (44.4%) 0.981‡
Diagnosis
NC 104 (7.7%) 52 (7.7%) 52 (7.7%)
SCD 219 (16.2%) 116 (17.1%) 103 (15.2%)
MCI 138 (10.2%) 84 (12.4%) 54 (8.0%)
AD dementia 413 (30.5%) 209 (30.9%) 204 (30.1%)
non-AD dementia 235 (17.3%) 100 (14.8%) 135 (19.9%)
Other 246 (18.2%) 116 (17.1%) 130 (19.2%)
Missing responses on item level in the training set ranged from 10.5% (‘preparing
sandwich meals’) to 92.8% (‘programming a video recorder’). Approximately half
of the original version items (36/70) contained more than 50% missing data. Mean
ratings from the 33 experts ranged from 23.9 (‘programming a video recorder’) to
86.9 (‘paying when doing the shopping’), with an overall mean score of 62.3 (SD =
14.9).
3.2. Development of the short version. Figure 2 provides a flow-chart of the
item selection procedure. Our first step included the removal of 2 items that violated
the assumption of monotonicity, together with 7 items that contained more than
80% missing data. After the second round, we removed 11 items with missing
responses above 60% in all diagnostic groups and contributing little information to
the model (item information < 3.0). After the third round, we removed 8 items that
received low ratings of experts (mean rating < 50) and had often been commented
on as either unclear or redundant by respondents. We thereafter removed 6 items
with overlapping IIC’s and overlapping content with other items within the same
activity category (e.g. ‘cooking’ versus ‘preparing hot meals’). Of these overlapping
pairs, we removed the one containing higher missing data and lower content rating.
After the fourth round, we removed 4 items that were often perceived as unclear
and showed overlapping IIC’s with more specific items (e.g., ‘looking for important
things at home’ versus ‘looking for his/her keys’). Lastly, we removed 2 items due
to disputable item characteristics and additional comments of experts. Following
this, we refitted the model with the remaining 30 items and concluded that further
shortening was unnecessary. All 30 retained items in the training set were deemed
to contribute substantially unique information to the latent trait. The full GRM
model improved fit upon the constrained GRM model (LRT value = 98.01, df =
29, p < .001).
3.3. Validation of the short version. The final selection of items can be found
in Column 1 of Table 2. This selection adheres to all assumptions underlying the
IRT framework. The maximum acceleration factor on the consecutive eigenvalues
of the robust correlation matrix occurs at the second eigenvalue (with a value of
1.26), implying that the first eigenvalue (with a value of 17.09) dominates the
information content. Hence, a single latent dimension is sufficient. Moreover, no
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Original A-IADL-Q: 70 items 
61 items 
50 items 
42 items 
9 items removed due to 
- missing data > 80 % 
- violation IRT assumptions 
11 items removed due to:  
- missing data in all groups > 60% 
- item information value < 3.0 
8 items removed due to: 
- low expert ratings 
- often critizied by respondents  
6 items removed due to: 
- overlapping content within activity category 
- overlapping item information curves 
36 items 
4 items removed due to: 
- perceived as unclear by respondents 
- overlapping item information curves 
A-IADL-Q Short Version: 30 items 
32 items 
2 items removed due to: 
- additional comments of experts 
Figure 2. Flowchart of the item selection procedure that led to
the short version of the Amsterdam IADL Questionnaire (A-IADL-
Q). Abbreviation: IRT = Item Response Theory.
item pair sorted a residual correlation above .25 and no item displayed significant
violations of manifest monotonicity. Table 2 also presents information on missing
percentages and the estimated GRM parameters based on the validation set. The
last column shows the experts’ ratings. As can be seen, all retained items contain
less than 60% missing data and most items (26/30) had less than 50% missing
data in the validation set. The extremity parameters were spread along the latent
trait continuum (ranging from −4 to +4), which is also illustrated by the IIC’s
presented in Figure 3. For most items, item information values were above 3 (on
a total information of 163.68). Lastly, all short version items received medium to
high ratings from experts.
The full GRM model provided better fit on the validation data than the con-
strained GRM model (LRT value = 6644.47, df = 29, p < .001). The overall fit
of the final model was considered good: CFI = .994, RMSEA = .032. Internal
consistency of the short version was very high (robust McDonald’s omega = .98).
Concordance between the item sum-scores of the short version and the original
version also was very high (Kendall’s W = .97). Concordance with the MMSE
(Kendall’s W = .72) and DAD (Kendall’s W = .87) were high.
Table 3 presents the clinical characteristics of the different diagnostic groups
within the validation set. Figure 4 represents the trait score distributions for each
diagnostic group. It can be seen that this score seems to increase from normal
cognition to dementia. The variances of the trait scores were not equal between
diagnostic groups. Hence, a nonparametric test was employed to assess diagnostic-
group-differences between latent trait scores as derived from the final GRM model.
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Table 2. Final selection of the short version items, including
their missing data percentages, GRM parameters, item informa-
tion values and content ratings by experts. Abbreviations: GRM
= Graded Response Model, α = discrimination parameter, β’s =
extremity parameters. NOTE: Percentage missing, parameter es-
timates and information characteristics are based on the validation
set. Expert ratings were made per item on a visual analogue scale
ranging from 0 to 100.
Item % Missing Item Item Expert
param. information rating
α β1 β2 β3 β4
1 Carrying out household duties 12.1 1.830 -0.653 0.259 1.309 2.209 4.73 76
2 Doing the shopping 14.3 2.027 -0.597 0.481 1.206 1.732 4.93 79
4 Buying the correct articles 34.8 1.505 -0.209 0.795 1.249 1.282 2.57 73
6 Cooking 33.8 2.236 -0.613 0.426 0.990 1.388 5.25 76
9 Preparing sandwich meals 10.0 2.454 0.643 1.602 2.266 2.524 5.82 60
10 Making minor repairs to the house 53.1 2.330 -0.867 -0.013 0.510 0.897 5.28 60
11 Operating domestic appliances 8.3 2.120 -0.074 0.865 1.544 2.142 5.17 63
12 Operating the microwave oven 30.4 1.938 0.134 0.880 1.351 1.711 3.83 58
16 Operating the coffee maker 11.4 2.751 0.598 1.302 1.731 1.913 5.82 63
17 Operating the washing machine 42.0 3.662 0.584 1.254 1.533 1.610 7.71 58
19 Paying bills 34.4 2.659 -0.467 0.417 0.717 0.904 5.55 83
22 Using a mobile phone 17.0 2.126 -0.416 0.531 1.148 1.658 5.00 76
23 Managing the household budget 45.0 2.884 -0.773 0.138 0.448 0.738 6.56 79
25 Using electronic banking 46.9 3.632 -0.320 0.285 0.500 0.560 7.12 66
28 Using a pin code 11.8 2.030 0.190 1.082 1.533 1.984 4.34 77
29 Obtaining money from a cash machine 32.7 3.486 0.397 0.892 1.316 1.484 7.59 69
30 Paying using cash 15.6 2.665 0.415 1.288 1.712 2.257 6.59 72
31 Making appointments 17.4 1.945 -0.660 0.270 1.363 1.945 4.33 75
32 Filling in forms 24.8 2.516 -0.792 0.173 0.754 1.307 5.95 66
33 Working 47.1 1.579 -0.965 -0.237 0.379 0.742 2.95 70
35 Using a computer 22.6 2.229 -0.718 0.193 0.846 1.418 5.47 68
37 Emailing 44.0 3.100 -0.297 0.293 0.789 1.024 7.01 54
39 Printing documents 56.6 4.080 -0.059 0.653 0.814 0.857 8.3 70
46 Operating devices 16.4 3.374 -0.367 0.584 1.243 1.869 10.3 72
47 Operating the remote control 3.1 1.786 0.017 1.073 1.734 2.599 4.32 80
57 Playing card and board games 50.9 1.657 -0.462 0.556 1.194 1.662 3.49 62
59 Driving a car 25.7 1.592 -0.351 0.569 1.015 1.300 2.93 76
65 Using a sat-nav system 51.6 2.421 -0.394 0.384 0.777 0.823 4.62 61
66 Using public transport 47.9 3.123 -0.071 0.420 0.878 1.200 7.01 83
70 Being responsible for his/her own medication 27.7 1.478 -0.075 1.005 1.685 2.361 3.16 82
The Kruskal-Wallis rank sum test indicated that the mean trait score ranks of the
diagnosis groups indeed differed (χ2 = 187.01, df = 5, p < .001). Pairwise com-
parisons (Dunn’s test) with Bonferroni correction indicated the following pairwise
differences: (1) NC versus all other groups (all corrected p-values < .001); (2) SCD
versus AD dementia, non-AD dementia and Other group (all corrected p-values
< .001); and (3) MCI versus AD dementia (corrected p-value = .002).
4. Discussion
We designed a short version of the A-IADL-Q (A-IADL-Q-SV) containing 30
items. We thereby reduced administration time by approximately 10 minutes. We
showed that, although significantly shorter, the A-IADL-Q-SV has maintained the
psychometric quality of the original version. We demonstrated adequate measure-
ment precision along the entire spectrum of IADL functioning. Short version scores
were in high concordance with the MMSE and DAD, which supports the construct
validity of the A-IADLQ-SV. We also found that the A-IADL-Q-SV could differen-
tiate between various diagnostic groups with respect to IADL impairment.
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Figure 3. Item information curves of the 30 Amsterdam IADL
items that resulted in the short version. The bold black line rep-
resents the total test information curve. The latent trait ranges
from −4 (good IADL functioning) to +4 (poor IADL functioning).
Table 3. Clinical characteristics of different diagnostic groups in
the validation set. Abbreviations: NC = normal cognition, SCD
= subjective cognitive decline, MCI = mild cognitive impairment,
AD = Alzheimers disease, MMSE = Mini-Mental State Examina-
tion (higher scores reflect better cognitive functioning), DAD =
Disability Assessment for Dementia (lower scores reflect more dys-
function in activities of daily living), N.A.= Not available for this
cohort.
NC SCD MCI AD dementia Non-AD dementia Other
(n = 52) (n = 103) (n = 54) (n = 204) (n = 135) (n = 130)
Female (%) 30 (57.7%) 43 (41.7%) 18 (33.3%) 111 (54.4%) 57 (42.2%) 42 (32.3%)
Age (SD) 70.5 (7.6) 62.8 (10.2) 69.8 (9.3) 66.9 (8.9) 66.5 (8.5) 60.8 (9.9)
MMSE score (SD) N.A. 27.3 (2.2) 26.6 (2.1) 20.1 (4.8) 23.7 (4.4) 25.3 (4.3)
DAD score (SD) N.A. 91.0 (12.6) 86.5 (14.3) 78.2 (20.6) 75.7 (25) 76.6 (23.7)
The current study expands on previous work on the A-IADL-Q, which already
demonstrated good psychometric quality of the scale [18-21]. The A-IADL-Q-SV
contains only the most informative items, and thereby possible ‘noise’ caused by less
informative or ambiguous items has been reduced. Because of its reduced length,
the A-IADL-Q-SV may be perceived as a more user-friendly measure. The use of
shorter tests is also encouraged from a psychometric point of view: a short form
containing items of the same quality as the original form may yield less measurement
error and thus be more reliable [28]. Longer tests are more likely to suffer from
acquiescence bias and missing responses. Using the A-IADL-Q-SV may overcome
these test-length related drawbacks.
Our findings suggest that the A-IADL-Q-SV can already detect IADL problems
in subjects with SCD and MCI, which is in line with previous studies that report
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Figure 4. Short version latent trait scores for each diagnostic
group. Latent trait scores reflect IADL functioning, with higher
scores indicating poorer IADL functioning. Post-hoc analyses gave
the following significant pairwise differences: 1) NC vs. all other
groups; 2) SCD vs. AD dementia, non-AD dementia and Other
group; and 3) MCI vs. AD dementia. Abbreviations: NC = nor-
mal cognition, SCD = subjective cognitive decline, MCI = mild
cognitive impairment, AD = Alzheimer’s disease.
subtle functional impairment in these groups [46-48]. We found that IADL scores
differed between subjects with NC and SCD. This is of particular interest since
both groups are characterized by the absence of objective cognitive impairment,
although SCD subjects may be at higher risk of developing dementia [49]. The
A-IADL-Q-SV might thus be able to detect subtle functional decline that appears
in preclinical stages of dementia, suggesting that it could be a promising measure
for clinical trials in these earliest stages [10,50].
Strengths of this study include our large and heterogenic sample with subjects
covering a broad range of the IADL spectrum along the continuum from normal
ageing to dementia. Another strength is the use of a validation set to replicate
findings derived from the training set. After splitting the total sample, the train-
ing and validation set both contained more than 500 subjects, a number that is
recommended for estimating accurate parameters based on the GRM [51]. Finally,
combining statistical methods with input from respondents and experts is an im-
portant strength of this study, as it preserved both the psychometric quality and
clinical relevance of the A-IADL-Q-SV.
There are some limitations that should be considered. Among them are our
relatively small NC group, due to the fact that most subjects were recruited via
memory clinics. Secondly, previous studies have shown that proxy-based IADL
measures may be confounded by respondent characteristics such as caregiver burden
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and depression [52]. We did not take these characteristics into account in the
current study. However, Sikkes et al. showed low correlations between the original
A-IADL-Q, caregiver burden and depression, indicating limited confounding by
these variables [19].
Further research is needed to examine whether the A-IADLQ-SV is sensitive to
changes over time within subjects. We will investigate the A-IADL-Q-SV longitu-
dinally in subjects with MCI and early dementia, in order to determine whether
it could be an effective measure for monitoring disease progression and evaluating
disease-modifying therapies. Since the research field is shifting towards preclinical
stages of dementia, it is also relevant to further investigate the A-IADL-SV in sub-
jects with SCD and the relation between IADL scores and dementia biomarkers in
this group.
To conclude, we developed a short version of the A-IADL-Q, which is a concise
instrument to efficiently measure functional decline in the early stages of dementia.
The A-IADL-Q-SV has retained the good qualities of the original A-IADL-Q; hence,
we expect the short version to be a promising outcome measure for daily function
in dementia research as well as in clinical practice.
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